Compare Sana Biotechnology Inc (SANA) vs United States Oil ETF (USO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs United States Oil ETF — how do they compare? Sana Biotechnology Inc trades at $2.8 (market cap $836.71M), while United States Oil ETF trades at $148.5 (market cap $1.90B). The key difference: United States Oil ETF is far larger — about 2.3× Sana Biotechnology Inc's market cap, and United States Oil ETF is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Sana Biotechnology Inc for 23 Days and United States Oil ETF for 21 Days on average.
| SANA | USO | |
|---|---|---|
Market Cap | $836.71M | $1.90B |
Volume | 4,507,444 | 5,932,922 |
Sector | Health | — |
52-Week High | $5.92 | $161.86 |
52-Week Low | $2.68 | $66.17 |
Typical Hold Time | 23 Days | 21 Days |
Enterprise Value | $749.96M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SANA Biotechnology trades at $2.84, up 4.41% today, while showing bearish technical signals with moving averages indicating selling pressure. The company remains pre-revenue with significant losses (-$244.17M net income in 2025) and negative cash flow from operations. Recent investor conference presentations highlight ongoing development of engineered cell therapies, though earnings have missed expectations in two of the last three quarters.
Despite analyst optimism (82% buy ratings), SANA faces substantial execution risk as a clinical-stage biotech with no current revenue and high cash burn. The stock's outlook depends heavily on clinical trial progress and future funding needs, with current valuation at 5.41x book value despite negative profitability metrics.
USO is trading at $148.32, up 3.06% today with a bullish technical signal supported by moving averages. The stock shows neutral oscillator readings with RSI at 63.03 suggesting balanced momentum. Recent news highlights oil market volatility from Middle East tensions and OPEC+ production decisions, creating both supply risks and price pressures.
The outlook remains cautiously optimistic given geopolitical tensions supporting oil prices, though G7 reserve releases and potential supply disruptions create conflicting forces. Key resistance sits at $150 with support at $146, making current levels critical for near-term direction amid volatile energy market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About United States Oil ETF
This ETF invests primarily in futures contracts for light, sweet crude oil, other types of crude oil, diesel-heating oil, gasoline, natural gas, and other petroleum-based fuels.
Read more on USO →
